Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection-Reference-Cited by-同舟云学术

Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection

Published:1998-07 Issue:1 Volume:28 Page:179-191
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Tennant Bud C.,Baldwin Betty H.,Graham Lou Ann,Ascenzi Mary A.,Hornbuckle William E.,Rowland Peter H.,Tochkov Ilia A.,Yeager Amy E.,Erb Hollis N.,Colacino Joseph M.,Lopez Carlos,Engelhardt Jeffery A.,Bowsher Ronald R.,Richardson Frank C.,Lewis William,Cote Paul J.,Korba Brent E.,Gerin John L.

Publisher

Wiley

Subject

Hepatology

Reference52 articles.

1. Preclinical investigations of FIAU, an anti-herpes agent. In: ed. Herpes Viruses and Viral Chemotherapy. New York: Elsevier Science Publishers, 1985;57-61.

2. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2

3. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

4. The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell

5. Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods;Pharmacological Reviews;2024-01-05

2. A mechanistic biomarker investigation of fialuridine hepatotoxicity using the chimeric TK-NOG Hu-liver mouse model and in vitro micropatterned hepatocyte cocultures;Toxicology Research;2024-01-01

3. Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B;Frontiers in Immunology;2022-05-23

4. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks;Cells;2021-09-05

5. Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B;Viruses;2021-04-09